Safety of conventional drugs and biologic agents for Rheumatoid Arthritis

A Amoroso; A Gigante; C Gianni; D Amoroso; D Zennaro; S Galluzzo; D Caccavo

Safety of conventional drugs and biologic agents for Rheumatoid Arthritis

Eur Rev Med Pharmacol Sci. 2003 Sep-Oct;7(5):139-45.

Authors

A Amoroso¹, A Gigante, C Gianni, D Amoroso, D Zennaro, S Galluzzo, D Caccavo

Affiliation

¹ Dpt. of Clinical Medicine, University of Rome La Sapienza, Italy.

PMID: 15214589

Abstract

While initial researches documented that Rheumatoid Arthritis (RA) patients who took biologic agents had decreased symptoms with those receiving traditional treatment, safety of the drugs remains a concern. The authors in this paper review the safety of the RA new therapeutic approach utilizing biological agents and compare it with the safety of conventional disease-modifying anti-rheumatic drugs (DMARDs).

Publication types

Comparative Study
Evaluation Study
Review

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Arthritis, Rheumatoid / drug therapy*
Arthritis, Rheumatoid / physiopathology
Clinical Trials, Phase III as Topic
Humans
Immunologic Factors / adverse effects*
Immunologic Factors / therapeutic use
Product Surveillance, Postmarketing / methods
Randomized Controlled Trials as Topic
Retrospective Studies

Substances

Anti-Inflammatory Agents, Non-Steroidal
Immunologic Factors